Prognostic impact of changes in circulating tumor cells (CTC) in metastatic breast cancer (MBC)

被引：0
|
作者：
Wallwiener, Markus
Hartkopf, Andreas D.
Riethdorf, Sabine
Sprick, Martin
Domschke, Christoph Wolfram
Schott, Sarah
Baccelli, Irene
Modugno, Caroline
Schoenfisch, Birgitt
Burwinkel, Barbara
Marme, Frederik
Heil, Joerg
Sohn, Christof
Pantel, Klaus
Trumpp, Andreas
Schneeweiss, Andreas
机构：
[1] Heidelberg Univ, Dept Obstet & Gynaecol, Heidelberg, Germany
[2] Univ Tubingen, Dept Gynecol & Obstet, Tubingen, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany
[4] DKFZ German Canc Res Ctr, Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany
[5] Univ Heidelberg Hosp, Heidelberg, Germany
[6] Heidelberg Univ, Dept Gynecol & Obstet, Natl Ctr Tumor Dis, Heidelberg, Germany
[7] German Canc Res Ctr, HI STEM, Heidelberg, Germany
[8] NTC Natl Ctr Tumour Dis, Heidelberg, Germany
[9] Dept Obstet & Gynaecol, Tubingen, Germany
[10] German Canc Res Ctr, Dept Mol Epidemiol, Heidelberg, Germany
[11] Univ Heidelberg Hosp, Dept Obstet & Gynecol, Heidelberg, Germany
[12] Univ Hosp Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany
[13] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cells (CTC): Assessment of treatment efficacy in metastatic breast cancer (MBC)
    Liu, M. C.
    Shields, P.
    Isaacs, C.
    Warren, R.
    Cohen, P.
    Wilkinson, M.
    Zhang, Y.
    Shen, R.
    Luyegu, K.
    Gallagher, A. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients
    Paoletti, Costanza
    Cani, Andi K.
    Aung, Kimberly
    Darga, Elizabeth P.
    Cannell, Emily M.
    Hovelson, Daniel H.
    Yazdani, Maryam
    Blevins, Allen R.
    Tokudome, Nahomi
    Baratta, Paul J.
    Larios, Jose' M.
    Thomas, Dafydd G.
    Brown, Martha E.
    Gersch, Christina
    Schott, Anne F.
    Robinson, Daniel
    Chinnaiyan, Arul M.
    Bischoff, Farideh
    Hayes, Daniel F.
    Rae, James M.
    Tomlins, Scott A.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Circulating tumor cells (CTC): A reliable predictor of treatment efficacy in metastatic breast cancer (MBC)
    Liu, M. C.
    Isaacs, C.
    Warren, R.
    Cohen, P.
    Wilkinson, M.
    Ottaviano, Y.
    Rao, S.
    Zhang, Y.
    Gallagher, A.
    Shields, P. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Somatic genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients
    Paoletti, C.
    Cani, A. K.
    Aung, K.
    Darga, E. P.
    Cannell, E. M.
    Hovelson, D. H.
    Yazdani, M.
    Blevins, A. R.
    Tokudome, N.
    Larios, J. M.
    Thomas, D. G.
    Brown, M. E.
    Gersch, C.
    Schott, A. F.
    Robinson, D. R.
    Chinnaiyan, A. M.
    Bischoff, F.
    Hayes, D. F.
    Rae, J. M.
    Tomlins, S. A.
    [J]. CANCER RESEARCH, 2016, 76
  • [5] Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC).
    Budd, GT
    Cristofanilli, M
    Ellis, MJ
    Stopeck, A
    Matera, J
    Miller, MC
    Doyle, GV
    Allard, WJ
    Terstappen, LW
    Hayes, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 4S - 4S
  • [6] CIRCULATING TUMOR CELLS (CTC) AND ARTIFICIAL NEURAL NETWORK (ANN) IN METASTATIC BREAST CANCER (MBC) PATIENTS
    Giordano, A.
    Giuliano, M.
    De Laurentiis, M.
    Eleuteri, A.
    Iorio, F.
    Tagliaferri, R.
    Reuben, J.
    Hortobagyi, G. N.
    de Placido, S.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 28 - 28
  • [7] Prognostic value of circulating tumor cells (CTC) in metastatic breast cancer (MBC): Correlation with immunohistochemically defined molecular subtypes and metastatic disease sites.
    Giordano, A.
    Giuliano, M.
    Hsu, L.
    Handy, B. C.
    Ueno, N. T.
    Andreopoulou, E.
    Alvarez, R. H.
    Valero, V.
    Hortobagyi, G. N.
    Cristofanilli, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Assessment of circulating tumor cells (CTC) by RT/PCR as a surrogate marker for PFS in metastatic breast cancer (MBC)
    Saber, M. M.
    Bahnasy, A. A.
    EI-Zawahry, H. M.
    Allahloubi, N. M.
    El-Moetii, M. A.
    Abd El Fatah, R. M.
    Aid, S.
    Ghareeb, M.
    [J]. CANCER RESEARCH, 2013, 73
  • [9] Circulating tumor cells (CTCs), CTC heterogeneity and distinct morphological CTC subtypes predict worse survival in metastatic breast cancer (MBC)
    O'Shaughnessy, Joyce A.
    Levin, Maren K.
    Rodriguez, Esther San Roman
    Lu, James
    Jones, Joshua T.
    Anderson, Amanda K. L.
    Tubbs, Alisa
    Schonhoft, Joseph D.
    Wenstrup, Rick
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [10] The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
    Wallwiener, Markus
    Hartkopf, Andreas Daniel
    Baccelli, Irene
    Riethdorf, Sabine
    Schott, Sarah
    Pantel, Klaus
    Marme, Frederik
    Sohn, Christof
    Trumpp, Andreas
    Rack, Brigitte
    Aktas, Bahriye
    Solomayer, Erich-Franz
    Mueller, Volkmar
    Janni, Wolfgang
    Schneeweiss, Andreas
    Fehm, Tanja Natascha
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 503 - 510
12345